Nicotinamide mononucleotide adenylyl transferase 1 protects against acute neurodegeneration in developing CNS by inhibiting excitotoxic-necrotic cell death
Philip B. Verghese(C2N Diagnostics (United States)), David M. Holtzman(Washington University in St. Louis), Steven Mennerick(Washington University in St. Louis), Donghan M. Yang(The University of Texas Southwestern Medical Center), Floy R. Stewart(Hope Center for Neurological Disorders), Yo Sasaki(SHOWA Medical University), Mary Beth Finn(Hope Center for Neurological Disorders), Jeffrey J. Neil(Washington University in St. Louis), Jeffrey Milbrandt(James S. McDonnell Foundation), Christine M. Wroge, Fatima Sabar
Cited by 62
Related Papers
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
|Immunity|2017|3k
National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards
|Stroke|2006|1.7k